Thomas Lee

Bitcoin and Ethereum spot ETFs experienced significant net outflows on Jan. 13, signaling a potential shift in market sentiment. What Happened: Bitcoin ETFs saw a combined net outflow of $284 million, while Ethereum ETFs recorded a total net outflow of $39.4 million, extending the outflow streak to...

Thomas Lee, co-founder of Fundstrat Global Advisors, took a bullish stance on Bitcoin (CRYPTO: BTC) in 2018. His position seems prescient in light of today’s market. What Happened: Lee’s central argument rested on the potential of Bitcoin to become a mainstream store of value. The Wall...

Ark Invest Founder Cathie Wood is among the big believers that the price of Bitcoin (CRYPTO: BTC) will rise. Ark Invest is among the companies that have filed to launch a Bitcoin ETF, an issue that awaits SEC approval. In an interview with Benzinga CEO Jason Raznick, Wood shared her...

Tom Lee, the Head of Research at FS Insight, predicted the potential growth trajectory of Bitcoin (CRYPTO: BTC) while speaking on CNBC Thursday, stating that the cryptocurrency's network value and inherent scarcity could push its price beyond the $200,000 mark. Lee's comments...

While the S&P 500 has rallied 8.9 percent in 2017, oil and energy investors have been left in the dust. The Energy Select Sector SPDR (ETF) (NYSE: XLE) is down 13.3 percent and the United States Oil Fund LP (ETF) (NYSE: USO) is down 16.8 percent on the year as WTI crude oil prices have once...

The S&P 500 has started off the month of May with a scary 1.9 percent selloff, but the credit markets are looking much more bullish. According to Fundstrat analyst Thomas Lee, the credit market is predicting that the S&P 500 may be in for a major bounce in coming months. “High-yield...

Fundstrat Global Advisors released a list of 23 stocks where "growth is cheaper than value." The report argued that investors still want "growth" even as they buy "value." The 23 S&P 500 growth stocks are cheaper than the S&P 500 Value Index. Fundstrat Global Advisors, a provider of...

Fundstrat believes that traders should be buying the dip in Healthcare stocks. The firm sees a compelling risk/reward balance in several quality healthcare stocks. History shows that buying Groups that have fallen 20 percent or more in a month typically generates strong returns. In a...

Thomas Lee, JPMorgan Chase (NYSE: JPM) Chief U.S. Equity Strategist, spoke on CNBC's Squawk Box on Monday morning, where he discussed where investors should put their money to work and why, as well as the place of the Fed in today's and tomorrow's market. "I think investors who have't put money...